SRT1720

Bezeichnung:SRT1720

CAS-Nr1001645-58-4

Englisch Name:SRT1720

CBNumberCB32512407

SummenformelC25H24ClN7OS

Molgewicht506.03

MOL-Datei1001645-58-4.mol

SRT1720 physikalisch-chemischer Eigenschaften

Schmelzpunkt	>205°C (dec.)
Dichte	1.58
storage temp.	= -70C
Löslichkeit	Soluble in DMSO (>25 mg/ml)
Aggregatzustand	Liquid
Farbe	White
Stabilität	Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.

Gefahreninformationscode (GHS)

SRT1720 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung
SRT1720 (1001645-58-4) is a SIRT1 activator (EC1.5 = 0.16 μM, max activation = 781%).1 It reduced glucose levels and hyperinsulinemia in DIO, Lepob/ob mice and Zucker fa/fa rats.? SRT1720 enhanced endurance running and protected against diet-induced obesity and insulin resistance via enhancement of oxidative metabolism in skeletal muscle, liver, and brown adipose tissue.2 It induced mitochondrial biogenesis in oxidant-induced renal proximal tube cell injury.3 SRT1720 repressed circadian clock gene expression and decreased H3 K9/K14 acetylation in a time-specific manner.4 It attenuated angiotensin II-induced atherosclerosis by inhibiting the vascular inflammatory response.5
Verwenden
SRT1720 acts as a therapeutic in the treatment of type 2 diabetes. It modulates calories and contributes to glucose homeostasis and insulin sensitivity.
Allgemeine Beschreibung
An enhanced aqueous soluble version of SRT1720 (Cat. No. 567860).
Biochem/physiol Actions
Cell permeable: yes
target
SIRT1
Einzelnachweise
Milne et al. (2007), Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes; Nature 450 712 Feige et al. (2008), Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation; Cell Metab. 8 347 Funk et al. (2010), SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells; J. Pharmacol. Exp. Ther. 333 593 Bellet et al. (2013), Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1; Proc. Natl. Acad. Sci. USA 110 3333 Chen et al. (2015), The Sirt1 activator SRT1720 attenuates angiotensin II-induced atherosclerosis in apoE-/- mice through inhibiting vascular inflammatory response; Biochem. Biophys. Res. Commun. 465 732

SRT1720 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Send Inquriy